Sawai to Buy Generic Biz of U.S. Drug Maker for 1.05 B. Dlrs

Sawai to Buy Generic Biz of U.S. Drug Maker for 1.05 B. Dlrs

   Osaka, April 20 (Jiji Press)--Japan's Sawai Pharmaceutical Co. <4555> said Thursday that it will acquire the generic drug business of U.S. peer Upsher-Smith Laboratories Inc. for 1.05 billion dollars.
   Sawai, based in the western Japan city of Osaka, will complete the acquisition by the end of June.

To read a full story, please click here to find out how to subscribe.

(C)JIJI PRESS LTD., All rights reserved.